Tue.Jul 09, 2024

article thumbnail

Bayer to largely complete layoffs within pharma commercial team in 2024, exec says

Fierce Pharma

Bayer’s massive reorganization championed by CEO Bill Anderson is bringing major changes to the German company’s pharma commercial team, shaking up its structure, personnel and operations. | Bayer’s massive reorganization championed by CEO Bill Anderson is bringing major changes to the German company’s pharma commercial team. And the division’s newly named commercial chief Christine Roth is among those changes.

Pharma 298
article thumbnail

Health Leaders Applaud HHS’ Action Giving Some Incarcerated Individuals Medicaid Coverage Before Release

MedCity News

Illinois, Kentucky, Oregon, Utah and Vermont have been authorized by HHS to provide Medicaid/Children’s Health Insurance Program coverage to those transitioning out of incarceration up to 90 days before they’re released. Several healthcare leaders called the action a necessary step. The post Health Leaders Applaud HHS’ Action Giving Some Incarcerated Individuals Medicaid Coverage Before Release appeared first on MedCity News.

Insurance 126
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

House Speaker Mike Johnson pledges vote for BIOSECURE as China-targeting bill hangs in limbo

Fierce Pharma

Ahead of an election in November—and amid a period of legislative uncertainty for the China-targeting BIOSECURE Act—U.S. | Ahead of an election in November—and amid a period of legislative uncertainty for the China-targeting BIOSECURE Act—U.S. House Speaker Mike Johnson has pledged to hold a vote for the controversial bill before the year is out.

294
294
article thumbnail

With New Huntington’s Gene Therapy Data, uniQure Hopes for Faster Path With FDA

MedCity News

A uniQure gene therapy for Huntington’s disease has interim clinical data showing an 80% slowing of disease progression. An accelerated approval pathway is one of the topics the company wants to discuss with the FDA. The post With New Huntington’s Gene Therapy Data, uniQure Hopes for Faster Path With FDA appeared first on MedCity News.

FDA 124
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

US government appeals Gilead's trial win in Truvada, Descovy patent fight

Fierce Pharma

As Gilead Sciences tussles with a web of HIV drug litigation, a high-stakes case tied to patents for prevention medicines is coming back to test the drugmaker. | As Gilead Sciences tussles with a web of HIV med litigation, a case tied to patents for prevention regimens of Truvada and Descovy is not quite settled. Late last week, the U.S. government appealed Gilead's prior win in the fight.

article thumbnail

Francis Crick and ICL spinout raises £90m to clinically develop cancer treatments

PharmaTimes

Myricx Bio’s therapies include treatments for breast, lung and colorectal cancer

119
119

More Trending

article thumbnail

SMC accepts Boehringer/Lilly’s Jardiance for CKD within NHS Scotland

PharmaTimes

The serious, progressive kidney disease affects nearly 850 million people worldwide

Medicine 116
article thumbnail

Elevar, Hengrui eye quick refile for PD-1 liver cancer combo after surprise FDA rejection

Fierce Pharma

Hengrui submitted a response to the FDA's Form 483 five months before the surprise rejection of its Elevar-partnered liver cancer combination.

FDA 200
article thumbnail

FTC report finds PBM power has “dire consequences”

pharmaphorum

A long-awaited report from the US Federal Trade Commission (FTC) on pharmacy benefit managers (PBMs) is out – and will make uncomfortable reading for the pharma supply chain middlemen.Its central message is clear. The six largest PBMs in the US manage nearly 95% of all prescriptions filled in the US, a “concentrated market structure” that has allowed them to “profit at the expense of patients and independent pharmacists,” according to the financial regulator.

article thumbnail

PhytoSquene® Assessed: Your plant-powered vaccine adjuvant

Fierce Pharma

Introduction | PhytoSquene® is the world’s first GMP-quality, plant-based squalene. Read this study to find out how it compares to shark-derived squalene.

140
140
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Could pharma’s blockbuster immunotherapies work in dogs?

PharmaVoice

Vetigenics believes it’s found a way to make pricey antibody-based technologies more accessible for animals.

111
111
article thumbnail

Digital health financing shows signs of recovery in H1

pharmaphorum

After languishing in the doldrums for a few quarters, there are signs that the winds of investment are starting to blow again in the US digital health sector.

111
111
article thumbnail

HarmonyCares Snags $200M to Scale Its In-Home Primary Care Model For Medicare & MA Plans

MedCity News

HarmonyCares raised $200 million dollars to scale its in-home primary care delivery model for high-risk senior patients. The money will be used to expand HarmonyCares’ market reach, particularly in the Medicare Advantage space — even as health systems continue to drop their MA contracts. The post HarmonyCares Snags $200M to Scale Its In-Home Primary Care Model For Medicare & MA Plans appeared first on MedCity News.

Marketing 108
article thumbnail

Mikael Dolsten exits Pfizer, putting R&D leadership in flux

pharmaphorum

Mikael Dolsten exits Pfizer, putting R&D leadership in flux Phil.

110
110
article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

Streamlining Healthcare: How Technology is Removing Friction for Providers

MedCity News

Here’s a look at three innovative software solutions that support healthcare transformation and are having a significant impact. The post Streamlining Healthcare: How Technology is Removing Friction for Providers appeared first on MedCity News.

article thumbnail

Agios Pharmaceuticals’ “Do You See It?” Campaign Featured in MM+M

Eversana Intouch

MM+M recently named Agios Pharmaceuticals’ “Do You See It?” campaign as their Campaign of the Week! The campaign focuses on the hidden dangers of thalassemia, a rare genetic condition affecting an estimated 8,000 Americans. The disease can result in anemia-like symptoms, with severe cases requiring regular blood transfusions, while milder cases often go untreated.

article thumbnail

Reining In the Wild West of AI

MedCity News

In healthcare, a faulty algorithm can be a matter of life and death. The post Reining In the Wild West of AI appeared first on MedCity News.

article thumbnail

Chromatography analysis for nitrosamine quantitation in pharmaceutical manufacturing water

European Pharmaceutical Review

Researchers have developed an ultrasensitive analytical method for quantifying nitrite quantity in process water for pharmaceutical products. The team tested various samples two ion chromatography analytical methods. This included a range of water types eg, purified and potable water, according to the paper. Kumar et al. explained that “accurate determination of nitrite content in process water will support an understanding of the potential for nitrosamine formation from nitrite in process water

article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

Roche will relaunch AMD implant Susvimo after update

pharmaphorum

Roche will reintroduce its Susvimo implant wet AMD, which was withdrawn from sale in 2022 due to manufacturing defects.

article thumbnail

Pharma Pulse 7/9/24: Technology Designed to Support Infertility, Patients with Type 1 Diabetes Have Higher Risk of Epilepsy & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

Pharma 102
article thumbnail

A spectrum of obesity requires precision

pharmaphorum

In this latest pharmaphorum podcast, web editor Nicole Raleigh speaks with Michael Kyle, chief medical officer at Currax Pharmaceuticals – a company working to advance a greater understanding of how to effectively treat obesity – about perceptions and options beyond the bounds of GLP-1s, including evolution of hypertension treatments.

Medical 102
article thumbnail

The Healthcare Interoperability Road Trip – “Are We There Yet?”

MedCity News

Achieving true national interoperability requires that all constituents have access to information that is trustworthy, accurate and presented in a way that is usable and actionable. The post The Healthcare Interoperability Road Trip – “Are We There Yet?” appeared first on MedCity News.

article thumbnail

Increase Revenue With Better, Faster Sales Onboarding

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

article thumbnail

FTC Report Acknowledges Impact Pharmacy Benefit Managers Have on Cost, Accessibility of Prescription Drugs

Pharmacy Times

In a new report, the FTC says pharmacy benefit managers act as middlemen in the pharmaceutical industry, leading to the squeezing of independent pharmacies and increases in prices for patients.

article thumbnail

Ligand grows in cancer again with $100m Apeiron takeover

pharmaphorum

Ligand grows in cancer again with $100m Apeiron takeover Phil.

59
article thumbnail

Study Connects Multivitamin Use With Mortality Risk

Pharmacy Times

Daily multivitamin users were associated with a 4% higher mortality risk compared to nonusers.

58
article thumbnail

Leveraging the Evolving Bioequivalence Regulatory Landscape to Enhance Product Design & Development

PharmaTech

Webinar Date/Time: Tue, Jul 30, 2024 11:00 AM EDT

52
article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

MedPharm, Tergus Pharma Join Forces

Pharmaceutical Commerce

The merger combines the companies under the MedPharma name, creating a topical and transepithelial CDMO in the process.

Pharma 52
article thumbnail

Biobetter Development

PharmaTech

Weighing development costs/resources and performance benefits is essential.

52
article thumbnail

FDA Approves Cordis’ Vascular Closure Device for Cardiac Ablation Procedures

PharmExec

Approval of the Mynx Control Venous vascular closure device was based on results from the ReliaSeal trial, which demonstrated 100% procedural and device success in cardiac ablation procedures.

FDA 52
article thumbnail

What the AHA Lawsuit Means for Healthcare and Tracking Tech

Penrod

The full AHA Lawsuit order can be read here. The order follows years of criticism from the AHA, who viewed the bulletin as an overextension of executive power that prevented providers from serving their communities via online trackers that improved web experiences. However, the order was surprisingly narrow in scope. What does this mean for providers?

article thumbnail

Using Generative AI in Sales: Pros, Cons, and Considerations According to Sellers

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A